Roche notes patent policy in sustainability report:
This article was originally published in Clinica
Executive Summary
Basel, Switzerland-based Roche has introduced a new sustainability report to be published in tandem with its usual annual report. The new document follows guidelines issued by the Global Reporting Initiative, a "multi-stakeholder initiative" comprising organisations as diverse as British American Tobacco and Oxfam International, working in partnership with various UN programmes. In the report, the company emphasises its policy of abstaining from patent enforcement in least developed countries and its financial support for health initiatives in Africa, as well as its progress in eco-efficiency.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.